SSKN: STRATA Skin Sciences, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 15.60
Enterprise Value ($M) 23.86
Book Value ($M) 12.69
Book Value / Share 0.36
Price / Book 1.23
NCAV ($M) -13.79
NCAV / Share -0.39
Price / NCAV -1.13

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.50

Liquidity (mrq)
Quick Ratio 1.06
Current Ratio 1.28

Balance Sheet (mrq) ($M)
Current Assets 15.54
Assets 42.02
Liabilities 29.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 33.36
Operating Income -6.32
Net Income -10.83
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic And Diluted Preferred Share n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -0.52
Cash from Investing -5.02
Cash from Financing 6.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Nantahala Capital Management, LLC 8.90 -28.80
08-18 13G/A 22NW Fund, LP 15.40 56.14

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-01 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPO
2023-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 46,882 134,130 34.95
2024-03-27 21,686 58,365 37.16
2024-03-26 13,068 29,356 44.52
2024-03-25 1,112 11,373 9.78

(click for more detail)

Similar Companies
SMLR – Semler Scientific, Inc. SMTI – Sanara MedTech Inc.
SRTS – Sensus Healthcare, Inc. STSS – Sharps Technology, Inc.
TIVC – Tivic Health Systems, Inc.


Financial data and stock pages provided by
Fintel.io